BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 34729298)

  • 1. Application of immune checkpoint targets in the anti-tumor novel drugs and traditional Chinese medicine development.
    Wang Y; Zhang X; Wang Y; Zhao W; Li H; Zhang L; Li X; Zhang T; Zhang H; Huang H; Liu C
    Acta Pharm Sin B; 2021 Oct; 11(10):2957-2972. PubMed ID: 34729298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bidirectional effects and mechanisms of traditional Chinese medicine.
    Peng X; Tang F; Yang Y; Li T; Hu X; Li S; Wu W; He K
    J Ethnopharmacol; 2022 Nov; 298():115578. PubMed ID: 35917892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Traditional Chinese Medicine in Cancer Immunotherapy: Current Status and Future Directions.
    Xie J; Huang H; Li X; Ouyang L; Wang L; Liu D; Wei X; Tan P; Tu P; Hu Z
    Am J Chin Med; 2023; 51(7):1627-1651. PubMed ID: 37638827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells.
    Kim N; Kim HS
    Front Immunol; 2018; 9():2041. PubMed ID: 30250471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer.
    Calabrese LH; Caporali R; Blank CU; Kirk AD
    J Autoimmun; 2020 Dec; 115():102546. PubMed ID: 32980229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional Chinese medicine and immune regulation.
    Ma HD; Deng YR; Tian Z; Lian ZX
    Clin Rev Allergy Immunol; 2013 Jun; 44(3):229-41. PubMed ID: 22826112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ["Efficacy Theory" may help to explain characteristic advantages of traditional Chinese medicines].
    Cai SQ; Wang X; Shang MY; Xu F; Liu GX
    Zhongguo Zhong Yao Za Zhi; 2015 Sep; 40(17):3435-43. PubMed ID: 26978986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands.
    Kamali AN; Bautista JM; Eisenhut M; Hamedifar H
    Ther Adv Vaccines Immunother; 2023; 11():25151355231192043. PubMed ID: 37662491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical pharmacokinetics-related pharmacological effects of orally administered polysaccharides from traditional Chinese medicines: A review.
    Ye D; Zhao Q; Ding D; Ma BL
    Int J Biol Macromol; 2023 Dec; 252():126484. PubMed ID: 37625759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Research on the Mechanisms Underlying Immune Checkpoints and Tumor Metastasis.
    Tang XY; Shi AP; Xiong YL; Zheng KF; Liu YJ; Shi XG; Jiang T; Zhao JB
    Front Oncol; 2021; 11():693321. PubMed ID: 34367975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases.
    Cai X; Zhan H; Ye Y; Yang J; Zhang M; Li J; Zhuang Y
    Front Genet; 2021; 12():785153. PubMed ID: 34917131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor effects and mechanisms of Astragalus membranaceus (AM) and its specific immunopotentiation: Status and prospect.
    Li S; Sun Y; Huang J; Wang B; Gong Y; Fang Y; Liu Y; Wang S; Guo Y; Wang H; Xu Z; Guo Y
    J Ethnopharmacol; 2020 Aug; 258():112797. PubMed ID: 32243990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of immune checkpoint therapy in autoimmune diseases.
    Mohammadi P; Hesari M; Chalabi M; Salari F; Khademi F
    Int Immunopharmacol; 2022 Jun; 107():108647. PubMed ID: 35228033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functions of Immune Checkpoint Molecules Beyond Immune Evasion.
    Zhang Y; Zheng J
    Adv Exp Med Biol; 2020; 1248():201-226. PubMed ID: 32185712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes.
    Pesce S; Trabanelli S; Di Vito C; Greppi M; Obino V; Guolo F; Minetto P; Bozzo M; Calvi M; Zaghi E; Candiani S; Lemoli RM; Jandus C; Mavilio D; Marcenaro E
    Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33255582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune checkpoint therapy in liver cancer.
    Xu F; Jin T; Zhu Y; Dai C
    J Exp Clin Cancer Res; 2018 May; 37(1):110. PubMed ID: 29843754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic effects of traditional chinese medicine on COVID-19: a narrative review.
    Wang C; Sun S; Ding X
    Int J Clin Pharm; 2021 Feb; 43(1):35-45. PubMed ID: 32974857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effects of traditional Chinese medicine targeting the cellular apoptotic pathway.
    Xu H; Zhao X; Liu X; Xu P; Zhang K; Lin X
    Drug Des Devel Ther; 2015; 9():2735-44. PubMed ID: 26056434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gene expression profiles in response to 102 traditional Chinese medicine (TCM) components: a general template for research on TCMs.
    Lv C; Wu X; Wang X; Su J; Zeng H; Zhao J; Lin S; Liu R; Li H; Li X; Zhang W
    Sci Rep; 2017 Mar; 7(1):352. PubMed ID: 28336967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive review of recent studies on pharmacokinetics of traditional Chinese medicines (2014-2017) and perspectives.
    Shi P; Lin X; Yao H
    Drug Metab Rev; 2018 May; 50(2):161-192. PubMed ID: 29258334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.